Great Waters Wealth Management Lowers Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Great Waters Wealth Management reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the first quarter, HoldingsChannel reports. The firm owned 17,237 shares of the healthcare conglomerate’s stock after selling 347 shares during the period. UnitedHealth Group comprises about 1.3% of Great Waters Wealth Management’s portfolio, making the stock its 13th biggest holding. Great Waters Wealth Management’s holdings in UnitedHealth Group were worth $9,028,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Norges Bank purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $6,375,744,000. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,914,740,000. Amundi raised its stake in shares of UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $303.24 on Monday. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock has a market cap of $275.08 billion, a PE ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s fifty day moving average price is $409.03 and its 200-day moving average price is $482.60.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm posted $6.91 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.92%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s dividend payout ratio is 37.02%.

Analyst Upgrades and Downgrades

UNH has been the topic of several analyst reports. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research note on Thursday, May 15th. Mizuho decreased their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Wall Street Zen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Oppenheimer decreased their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $428.43.

Insider Activity at UnitedHealth Group

In other news, Director John H. Noseworthy acquired 300 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kristen Gil purchased 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.